No-Prophylaxis Prophylaxis P value
Number of patients Autologous Allogeneic 119 73 46 100 51 49 0.124
Age Median(range) 45 years (2 to 68 years) 34.5 (1 to 68years) 0.005
Diagnosis Diagnosis Diagnosis Diagnosis
Autologous Myeloma Lymphoma Others 51 14 4 35 11 1
Allogeneic Leukemia MDS MPN Haemoglobinopathies Aplastic Anemia Others 24 3 2 13 5 3 15 3 1 15 8 8
Conditioning regimen Myeloablative Reduced intensity 95 (79.8%) 24 (20.2%) 86 (86%) 14 (14%)
Allogeneic transplant Matched Sibling Donor Matched unrelated Donor Haploidentical 46 31 (67.4%) 5 (10.9%) 10 (21.7%) 49 40 (81.6%) 4 (8.2%) 5 (10.2%)
CD 34 dose Median (range) 5.10 x 106/kg (2.0 to 23.0x 106/kg) 3.91x 106/kg (1.0 to 17.0x 106/kg) 0.111
Neutrophil engraftment Median(range) 11 Days (12 to 31 Days) 12 Days (9 to 35 Days) 0.024
Platelet engraftment Median(range) 11 Days (12 to 25 Days) 12 (10 to 117 Days) 0.004
Hospital stay Median (range) 23 Days (12 to 71) 25 Days (13 to 149) 0.132